Announcement of TTY Biopharm's unaudited income information in September 2021
2021.10.13
Provided by: TTY BIOPHARM COMPANY LIMITED
| SEQ_NO | 1 | Date of announcement | 2021/10/13 | Time of announcement | 16:51:02 |
| Subject | Announcement of TTY Biopharm's unaudited income information in September 2021 | ||||
| Date of events | 2021/10/13 | To which item it meets | paragraph 53 | ||
| Statement | 1.Date of occurrence of the event:2021/10/13 2.Company name:TTY Biopharm Co., Ltd. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:N/A 5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $389,573 thousands (expressed in NT dollars; unaudited), a consolidated operating profit of $123,806 thousands, and a consolidated income before tax of $147,535 thousands in September 2021; net income attributed to stockholders of the parent company was $122,896 thousands; EPS is $0.49. Year-to-date consolidated net sales was $3,067,163 thousands (in NT dollars; unaudited), a consolidated operating profit was $763,880 thousands and consolidated income before tax was $663,181 thousands until September 2021; year-to-date net income attributed to stockholders of the company was $489,744 thousands; EPS is $1.97. 6.Countermeasures:N/A 7.Any other matters that need to be specified: The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail. |
||||